NEO:NASDAQ
NeoGenomics, Inc.
$19.86
arrow_downward
-0.28%(-0.055) 1D
Sep 21, 9:53:38 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEO...
Open
$19.92
High
$20.05
Low
$19.55
Mkt. cap
2.55B
Avg. vol.
1.76M
Volume
121.56K
52-wk high
$20.05
52-wk low
$7.06
EPS
-$0.40
Beta
1.75
Shares outstanding
128.48M
No. of employees
2K
Open
$19.92
High
$20.05
Low
$19.55
Mkt. cap
2.55B
Avg. vol.
1.76M
Volume
121.56K
52-wk high
$20.05
52-wk low
$7.06
EPS
-$0.40
Beta
1.75
Shares outstanding
128.48M
No. of employees
2K
News stories
From web sources and news partners
Yahoo Finance Singapore
·
52 minutes ago
Is NeoGenomics’ (NEO) Community NGS Push Quietly Redefining Its Core Earnings Engine?
Yahoo Finance
·
12 hours ago
NeoGenomics Highlights NGS, MRD Growth Strategy at Morgan Stanley Conference
CarePlus VietNam
·
1 month ago
NeoGenomics (NEO) Slips to $16.50 as Biotech Diagnostic Stocks Face Cautious Trading - Trading Ideas
CarePlus VietNam
·
1 month ago
NeoGenomics (NEO) Drops 2.5% as Stock Approaches Critical Support Near $13.2 - Momentum Trade
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
About NeoGenomics, Inc.
CEOChristopher M. Smith
Employees2.5K
Founded2002
HeadquartersFort Myers, Florida, United States
SectorHealth care provider
Websiteneogenomics.com